Skip to main content
CDC Website

TB

TB

4R Regimen for Latent TB Infection Medication Tracker and Symptom Checklist (Pashto)

This material was developed for clinicians to use with patients that are prescribed the four months daily rifampin (4R) regimen for the treatment of latent TB infection. There is space to write treatment information, medication intake, and doctor/clinic contact information. There is also a checklist of signs and symptoms that may develop while using the 4R regimen.

12-Dose Regimen for Latent TB Infection Medication Tracker and Symptom Checklist (Pashto)

This material was developed for clinicians to use with patients that are prescribed the 12-dose regimen for the treatment of latent TB infection. There is space to write treatment schedules, medication intake, and doctor/clinic contact information. There is also a checklist of signs and symptoms that may develop while using the 12-dose regimen.

12-Dose Regimen for LTBI Patient Education Brochure (Pashto)

The patient education brochure was developed for clinicians to use with patients while discussing the 12-dose regimen for the treatment of latent TB infection. The brochure contains information on latent TB infection, the 12-dose regimen, and adverse events.

You Can Prevent Tuberculosis: A Patient Educational Handout

The handout describes the main characteristics of LTBI and Active TB, as well as their differences. The material also describes what increases the risk for developing Active TB and how to prevent TB from developing. English is on one side and Mandarin is on the other.

4R Regimen for Latent TB Infection Medication Tracker and Symptom Checklist (Dari)

This material was developed for clinicians to use with patients that are prescribed the four months daily rifampin (4R) regimen for the treatment of latent TB infection. There is space to write treatment information, medication intake, and doctor/clinic contact information. There is also a checklist of signs and symptoms that may develop while using the 4R regimen.

12-Dose Regimen for Latent TB Infection Medication Tracker and Symptom Checklist (Dari)

This material was developed for clinicians to use with patients that are prescribed the 12-dose regimen for the treatment of latent TB infection. There is space to write treatment schedules, medication intake, and doctor/clinic contact information. There is also a checklist of signs and symptoms that may develop while using the 12-dose regimen.

You Can Help Stop TB in New York City!

Infographic for New York City citizens on how to stop TB.

TB Alliance Stakeholders Association 2022 Virtual Meeting

Today, TB Alliance held a virtual meeting of its Stakeholders Association and other tuberculosis (TB) and global health stakeholders around the world to highlight the recent rapid communication issued by the World Health Organization (WHO) Global Tuberculosis Programme regarding updated guidelines for treating drug-resistant tuberculosis (DR-TB) and their potential impact on DR-TB therapy.

Fight TB: Know the signs and symptoms

Since January of 2016, we have seen an increase of multidrug-resistance tuberculosis (MDR TB) in Minnesota. The severe increase in these rates is due to an MDR TB outbreak within the Hmong community of the east metro. What is very concerning about this outbreak is that it is not regular TB, but MDR TB. This means some of the typical medicines used to treat TB do not work, and we need to use stronger medications over a long period of time to get rid of the disease.

Think TB

Infographic: Refer clients with symptoms lasting more than 2-3 weeks to a medical provider immediately. Clients with infectious TB disease should not be in group settings.